Tarn Biosciences
PrivateLast Round
Grant
Sep 1, 2023
Total Funding Raised
$1.25M
Company Overview
Tarn Biosciences operates in Healthcare & Life Sciences and is based in East Lansing, Michigan. Its latest recorded funding round was a Grant round in September 2023.
Tarn Biosciences is a biotechnology company that develops novel therapies for tuberculosis and non-tuberculous mycobacterial infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tarn Biosciences Comparables
Compare Tarn Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hsiri Therapeutics | 81% | |
| Sequella, Inc. | 78% | |
| Spero Therapeutics, Inc. | 70% |
For institutional investors. Book with your work email.
Tarn Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 1, 2023 | ||||
| Grant | Jul 6, 2023 | ||||
| Grant | Aug 19, 2022 |
For institutional investors. Book with your work email.
Tarn Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Spartan Innovations | Seed |
| National Institutes of Health (NIH) | Grant |
| Small Business Administration | Grant |
| Michigan Economic Development Corporation | Grant |
| Michigan Rise and Red Cedar Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2023
$587K grant received from the National Institutes of Health.
- Aug 19, 2022
$40K grant from Michigan Economic Development Corporation
For institutional investors. Book with your work email.
Tarn Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Tarn Biosciences's valuation, stock price, and market status.
Is Tarn Biosciences a public or private company?
Tarn Biosciences is a private company.
What is the current stock price of Tarn Biosciences?
Tarn Biosciences is a private company, so its shares have no public market price. Caplight tracks Tarn Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Tarn Biosciences worth (valuation)?
Valuation information for Tarn Biosciences is not publicly available.
Can I buy Tarn Biosciences stock?
Tarn Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Tarn Biosciences's last funding round?
Tarn Biosciences's most recent funding round was Grant on September 1, 2023.
Who are the main investors in Tarn Biosciences?
Key investors in Tarn Biosciences include Spartan Innovations, National Institutes of Health (NIH), Small Business Administration, Michigan Economic Development Corporation, Michigan Rise and Red Cedar Ventures.
Will Tarn Biosciences IPO soon?
No public IPO plans have been announced for Tarn Biosciences.
How can I track Tarn Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Tarn Biosciences's shares on secondary markets.